Bruce G Jenkins

Title: Bruce G Jenkins: Innovator in Neurological Imaging

Introduction

Bruce G Jenkins is a notable inventor based in Belmont, MA (US). He has made significant contributions to the field of medical imaging, particularly in the diagnosis of neurological and psychiatric diseases. His innovative approach utilizes advanced techniques in Magnetic Resonance Imaging (MRI) to enhance diagnostic accuracy.

Latest Patents

Jenkins holds a patent for a method titled "Method for diagnosing neurological, neurodegenerative and psychiatric diseases by magnetic resonance imaging using contrast agents with high magnetic susceptibility and extended plasma half life." This patent describes a method for MRI that assesses changes in neurotransmitter and neuroreceptor activity as a metabolic response to diagnostic challenges or therapeutic treatments. The process involves administering a drug to elicit an MRI detectable hemodynamic response, followed by the use of a contrast agent with high magnetic susceptibility. The method allows for the measurement of relative Cerebral Blood Volume (rCBV) changes associated with neuronal activation using T1- or T2-weighted MRI scans.

Career Highlights

Throughout his career, Jenkins has focused on advancing the capabilities of MRI technology. His work has the potential to revolutionize the way mental illnesses are diagnosed and treated. He is currently associated with Bracco S.p.a., a company known for its innovations in medical imaging.

Collaborations

Jenkins has collaborated with esteemed colleagues such as Joe B Mandeville and Friedrich M Cavagna. These partnerships have contributed to the development of cutting-edge imaging techniques and methodologies.

Conclusion

Bruce G Jenkins is a pioneering inventor whose work in MRI technology is making a significant impact in the field of neurological and psychiatric diagnostics. His innovative methods are paving the way for improved patient outcomes and advancing medical imaging practices.